releases: https://morgangriffith.house.gov/news/documentsingle.aspx?DocumentID=405839
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://morgangriffith.house.gov/news/documentsingle.aspx?DocumentID=405839 | Griffith Announces $191,331 HHS Grant to Biotherapeutics, Inc. | 2026-09-28 | 2026 | 2026-09 | Republican | House | VA | H. Morgan Griffith | G000568 | morgangriffith.house.gov | morgangriffith | https://morgangriffith.house.gov/news/ | scraper | The U.S. Department of Health and Human Services (HHS) has awarded Biotherapeutics, Inc., based in Blacksburg, Virginia, a $191,331 grant. The funding supports research into therapies for psoriasis. In response to this grant notice, U.S. Congressman Morgan Griffith (R-VA) issued the following statement: “Psoriasis is a skin disease that affects millions of Americans. “This grant for more than $191,000 helps Biotherapeutics, Inc. study a first-in-class treatment for psoriasis.” BACKGROUND As a member of the House Committee on Energy and Commerce, Congressman Griffith serves as the Chairman of the Health Subcommittee. Last week, Congressman Griffith announced a separate $500,000 HHS grant to Biotherapeutics, Inc. ### | 1 | 2026-09-29T11:07:12Z | 2026-09-29T11:08:49Z |